# A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

> **NCT01255371** · PHASE3 · WITHDRAWN · sponsor: **ANRS, Emerging Infectious Diseases**

## Conditions studied

- HIV

## Interventions

- **DRUG:** Lopinavir
- **DRUG:** Atazanavir

## Key facts

- **NCT ID:** NCT01255371
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2013-05
- **Final completion:** 2014-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** drug procurement issues
- **Last updated:** 2012-11-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01255371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01255371, "A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01255371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*